how long should i take retatrutide VisualAbstract: reduces body weight by 17.5% in patients with obesity Understanding the Retatrutide starting dose

While GLP-1s are generally well tolerated and offer numerous health benefits from weight loss and better glucose control to a lower risk of cardiovascular disease research suggests they could increase the risk of certain serious eye conditions

Nausea, vomiting or diarrhoea, particularly at the beginning of the treatment or during dose increases, can further deplete fluids and electrolytes

GLP-1 drugs seem to offer the best chance to tilt the scales back in our favor

This article originally appeared on USA TODAY: Weight-loss drugs draw thousands of lawsuits alleging serious harm Reporting by Chris Kenning and Austin Fast, USA TODAY / USA TODAY USA TODAY Network via Reuters Connect